The Discounted Cash Flow (DCF) valuation of United Therapeutics Corp (UTHR) is 453.23 USD. With the latest stock price at 295.52 USD, the upside of United Therapeutics Corp based on DCF is 53.4%.
Based on the latest price of 295.52 USD and our DCF valuation, United Therapeutics Corp (UTHR) is a buy. buying UTHR stocks now will result in a potential gain of 53.4%.
| Range | Selected | |
| WACC / Discount Rate | 7.6% - 9.6% | 8.6% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 366.67 - 614.93 | 453.23 |
| Upside | 24.1% - 108.1% | 53.4% |